Frédéric Clément

3.3k citations
45 papers · 2.6k · h-index 24

Impact in

  • Virology top 5%
  • Immunology top 5%
    • Immunotherapy and Immune Responses
    • Immune Response and Inflammation
    • Immune Cell Function and Interaction

Papers in

  • Epidemiology 25
    • Influenza Virus Research Studies 10
    • Hepatitis B Virus Studies 7
    • Herpesvirus Infections and Treatments 4
  • Virology 8
    • HIV Research and Treatment 8
Co-authors
Geert G Leroux-Roels (31 shared papers)Isabel Leroux‐Roels (8 shared papers)Mamadou Dramé (2 shared papers)Philippe Moris (6 shared papers)Astrid Borkowski (2 shared papers)Thomas Vanwolleghem (1 shared paper)Jeanne‐Marie Devaster (1 shared paper)Pierre Vandepapelière (4 shared papers)
Journals
Vaccine (5 papers)Frontiers in Immunology (5 papers)Clinical and Vaccine Immunology (4 papers)Human Vaccines & Immunotherapeutics (4 papers)Journal of Immunological Methods (3 papers)
Partner nations
BelgiumUnited StatesUnited Kingdom

In The Last Decade

Frédéric Clément

41 papers receiving 2.5k citations

Peers

Frédéric Clément
Comparison fields: 5 of 108
  • Virology 221
  • Immunology 909
  • Infectious Diseases 654
  • Epidemiology 1.1k
  • Microbiology 106
Replace Angelika Banzhoff with:
Angelika Banzhoff Germany
Michele A. Kutzler United States
Ian J. Amanna United States
Soumaya Bennouna United States
Eric M. Feeley United States
Masahiro Niikura Japan
Stefan Niewiesk United States
Gloria Agatic Switzerland
Veronika von Messling Germany
Katia Abarca Chile
Frédéric Clément relative to Angelika Banzhoff Germany Angelika Banzhoff's profile →
Citations per field
00.5×2×3.3×
Angelika Banzhoff · 1×
Citations per year

Countries citing papers authored by Frédéric Clément

Since Specialization
Citations

This map shows the geographic impact of Frédéric Clément's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Clément with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Clément more than expected).

Fields of papers citing papers by Frédéric Clément

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédéric Clément. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Clément. The network helps show where Frédéric Clément may publish in the future.

Co-authors

The 25 scholars most cited alongside Frédéric Clément, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Frédéric Clément Line = papers co-authored together Frédéric Clément links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial
The Lancet ·Isabel Leroux‐Roels, Astrid Borkowski, Thomas Vanwolleghem, Mamadou Dramé, Frédéric Clément, Eliane Hons, Jeanne‐Marie Devaster, Geert G Leroux-Roels
2007457
2
Genetic Adaptation and Neandertal Admixture Shaped the Immune System of Human Populations
Cell ·Hélène Quach, Maxime Rotival, Julien Pothlichet, Yong‐Hwee Eddie Loh, Michael Dannemann, Nora Zidane, Guillaume Laval, Étienne Patin
2016314
3
Pro- and anti-inflammatory responses of peripheral blood mononuclear cells induced by Staphylococcus aureus and Pseudomonas aeruginosa phages
Scientific Reports ·Jonas D. Van Belleghem, Frédéric Clément, Maya Merabishvili, Rob Lavigne, Mario Vaneechoutte
2017207
4
Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers
Vaccine ·Pierre Vandepapelière, Yves Horsmans, Philippe Moris, Marcelle Van Mechelen, Michel Janssens, Marguerite Koutsoukos, Pascale Van Belle, Frédéric Clément
2008195
5
H5N1 Influenza Vaccine Formulated with AS03A Induces Strong Cross-Reactive and Polyfunctional CD4 T-Cell Responses
Journal of Clinical Immunology ·Philippe Moris, Robbert van der Most, Isabel Leroux‐Roels, Frédéric Clément, Mamadou Dramé, Emmanuel Hanon, Geert G Leroux-Roels, Marcelle Van Mechelen
2010145
6
Improved CD4+ T cell responses to Mycobacterium tuberculosis in PPD-negative adults by M72/AS01 as compared to the M72/AS02 and Mtb72F/AS02 tuberculosis candidate vaccine formulations: A randomized trial
Vaccine ·Isabel Leroux‐Roels, Sheron Forgus, Fien De Boever, Frédéric Clément, Marie‐Ange Demoitié, Pascal Mettens, Philippe Moris, Edouard Ledent
2012138
7
A Phase 1/2 Clinical Trial Evaluating Safety and Immunogenicity of a Varicella Zoster Glycoprotein E Subunit Vaccine Candidate in Young and Older Adults
The Journal of Infectious Diseases ·Isabel Leroux‐Roels, Geert G Leroux-Roels, Frédéric Clément, Pierre Vandepapelière, Ventzislav B. Vassilev, Edouard Ledent, Thomas Charles Heineman
2012130
8
Different Adjuvants Induce Common Innate Pathways That Are Associated with Enhanced Adaptive Responses against a Model Antigen in Humans
Frontiers in Immunology ·Wivine Burny, Andrea Callegaro, Viviane J. Bechtold, Frédéric Clément, Sophie Delhaye, Laurence A Fissette, Michel Janssens, Geert G Leroux-Roels
2017123
9
Impact of adjuvants on CD4+ T cell and B cell responses to a protein antigen vaccine: Results from a phase II, randomized, multicenter trial
Clinical Immunology ·Geert G Leroux-Roels, Arnaud Marchant, Jack Lévy, Pierre Van Damme, Tino F. Schwarz, Yves Horsmans, Wolfgang Jilg, Peter Gottfried Kremsner
2016100
10
Strong and persistent CD4+ T-cell response in healthy adults immunized with a candidate HIV-1 vaccine containing gp120, Nef and Tat antigens formulated in three Adjuvant Systems
Vaccine ·Isabel Leroux‐Roels, Marguerite Koutsoukos, Frédéric Clément, Sophia Steyaert, Michel Janssens, Patricia Bourguignon, Kristen W. Cohen, Altfeld Marcus
201069
11
Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomes
PLoS ONE ·Geert G Leroux-Roels, Cathy Maes, Frédéric Clément, Frank van Engelenburg, Marieke van den Dobbelsteen, Michael W Adler, Mario Amacker, Lucia Lopalco
201366
12
An Adjuvanted Polyprotein HIV-1 Vaccine Induces Polyfunctional Cross-Reactive CD4+ T Cell Responses in Seronegative Volunteers
Clinical Infectious Diseases ·Eva Van Braeckel, Patricia Bourguignon, Marguerite Koutsoukos, Frédéric Clément, Michel Janssens, Isabelle Carletti, Alix Collard, Marie‐Ange Demoitié
201161
13
Evaluation of the immune response to RTS,S/AS01 and RTS,S/AS02 adjuvanted vaccines
Human Vaccines & Immunotherapeutics ·Geert G Leroux-Roels, Isabel Leroux‐Roels, Frédéric Clément, Opokua Ofori‐Anyinam, Marc Lievens, Erik Jongert, Philippe Moris, W. Ripley Ballou
201456
14
Effect on Cellular and Humoral Immune Responses of the AS03 Adjuvant System in an A/H1N1/2009 Influenza Virus Vaccine Administered to Adults during Two Randomized Controlled Trials
Clinical and Vaccine Immunology ·François P. Roman, Frédéric Clément, Walthère Dewé, Karl Walravens, Cathy Maes, Julie Willekens, Fien De Boever, Emmanuel Hanon
201147
15
Evaluation of the Safety and Immunogenicity of Two Antigen Concentrations of the Mtb72F/AS02ACandidate Tuberculosis Vaccine in Purified Protein Derivative-Negative Adults
Clinical and Vaccine Immunology ·Isabel Leroux‐Roels, Geert G Leroux-Roels, Opokua Ofori‐Anyinam, Philippe Moris, Els De Kock, Frédéric Clément, Marie‐Claude Dubois, Marguerite Koutsoukos
201044
16
The role of cell-mediated immunity against influenza and its implications for vaccine evaluation
Frontiers in Immunology ·Yorick Janssens, Jasper Joye, Gwenn Waerlop, Frédéric Clément, Geert G Leroux-Roels, Isabel Leroux‐Roels
202240
17
Validation of an enzyme-linked immunosorbent assay for the quantification of human IgG directed against the repeat region of the circumsporozoite protein of the parasite Plasmodium falciparum
Malaria Journal ·Frédéric Clément, Vincent Dewar, Eva Van Braeckel, Isabelle Desombere, Marianne Dewerchin, Christine Swysen, Marie‐Ange Demoitié, Erik Jongert
201238
18
Polyfunctional CD4+ T cell responses in HIV-1-infected viral controllers compared with those in healthy recipients of an adjuvanted polyprotein HIV-1 vaccine
Vaccine ·Eva Van Braeckel, Isabelle Desombere, Frédéric Clément, Linos Vandekerckhove, Chris Verhofstede, Dirk Vogelaers, Geert G Leroux-Roels
201333
19
Adjuvant-Associated Peripheral Blood mRNA Profiles and Kinetics Induced by the Adjuvanted Recombinant Protein Candidate Tuberculosis Vaccine M72/AS01 in Bacillus Calmette–Guérin-Vaccinated Adults
Frontiers in Immunology ·Robert A. van den Berg, Laurane De Mot, Geert G Leroux-Roels, Viviane J. Bechtold, Frédéric Clément, Margherita Coccia, Erik Jongert, Thomas G. Evans
201831
20
Superior immunogenicity of seasonal influenza vaccines containing full dose of MF59®adjuvant
Human Vaccines & Immunotherapeutics ·Giovanni Della Cioppa, Uwe Nicolay, KELLY A. LINDERT, Geert G Leroux-Roels, Frédéric Clément, Flora Castellino, Grazia Galli, Nicola Groth
201231

About Frédéric Clément

Frédéric Clément is a scholar working on Epidemiology, Virology, Immunology, Infectious Diseases and Public Health, Environmental and Occupational Health, having authored 45 papers that have together received 2.6k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (10 papers), HIV Research and Treatment (8 papers), Hepatitis B Virus Studies (7 papers), Immunotherapy and Immune Responses (5 papers), Immune Response and Inflammation (5 papers), Malaria Research and Control (4 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and Herpesvirus Infections and Treatments (4 papers). The work is most often cited by research in Virology (221 citations), Immunology (909 citations), Infectious Diseases (654 citations), Epidemiology (1.1k citations) and Microbiology (106 citations). Frédéric Clément has collaborated with scholars based in Belgium, United States and United Kingdom. Frequent co-authors include Geert G Leroux-Roels, Isabel Leroux‐Roels, Mamadou Dramé, Philippe Moris, Astrid Borkowski, Thomas Vanwolleghem, Jeanne‐Marie Devaster, Pierre Vandepapelière, Maya Merabishvili and Jonas D. Van Belleghem. Their work appears in journals such as Vaccine, Frontiers in Immunology, Clinical and Vaccine Immunology, Human Vaccines & Immunotherapeutics and Journal of Immunological Methods.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Angelika BanzhoffBreakdown of academic impact, for papers by Michele A. KutzlerBreakdown of academic impact, for papers by Ian J. AmannaBreakdown of academic impact, for papers by Soumaya BennounaBreakdown of academic impact, for papers by Eric M. FeeleyBreakdown of academic impact, for papers by Masahiro NiikuraBreakdown of academic impact, for papers by Stefan NiewieskBreakdown of academic impact, for papers by Gloria AgaticBreakdown of academic impact, for papers by Veronika von MesslingBreakdown of academic impact, for papers by Katia Abarca